Showing results (921-930 of 1,341) with videos related to

Sort By:
Pageof 135
Neuro-Oncology Advances|June 26, 2025
Repurposing the anthelmintic drug mebendazole in combination with radiation therapy in an isocitrate dehydrogenase mutant glioma modelAlex Shimura Yamashita, Marina da Costa Rosa, Gregory J Riggins
Neuro-Oncology Advances|June 30, 2025
Survivorship from pediatric and adult brain tumors: The 2024 Brain Tumor Epidemiology Consortium meeting reportScott L Coven, Roberta McKean-Cowdin, Michael E Scheurer, et al.
Neuro-Oncology Advances|September 11, 2025
Within and beyond the tumor: Mechanisms of glioblastoma-induced immunosuppressionBhairavy J Puviindran, Shannon Wallace, Katayoun Ayasoufi, et al.
Neuro-Oncology Advances|September 11, 2025
Immunologic specificity in glioblastoma: Antigen discovery and translational implicationsCameron M Hill, Anthony Z Wang, Brian Hsueh, et al.
Neuro-Oncology Advances|February 29, 2024
Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findingsNicole Briceno, Elizabeth Vera, Edina Komlodi-Pasztor, et al.
Neuro-Oncology Advances|February 27, 2024
Analysis of demographics and the impact of adjuvant radiotherapy on a nationwide cohort of patients with high-grade spinal meningiomasVictor Gabriel El-Hajj, Abdul Karim Ghaith, Ryan H Nguyen, et al.
Neuro-Oncology Advances|March 13, 2024
Unraveling the relations between post-traumatic stress symptoms, neurocognitive functioning, and limbic white matter in pediatric brain tumor patientsAnne E M Leenders, Eva Kremer-Hooft van Huijsduijnen, Bruno Robalo, et al.
Neuro-Oncology Advances|March 11, 2024
Tumor location and neurocognitive function-Unravelling the association and identifying relevant anatomical substrates in intra-axial brain tumorsKanchi Shah, Vinayak Bhartia, Chandrima Biswas, et al.
Neuro-Oncology Advances|March 15, 2024
Advancements in chimeric antigen receptor-expressing T-cell therapy for glioblastoma multiforme: Literature review and future directionsMichael Goutnik, Alexandria Iakovidis, Megan E H Still, et al.
Neuro-Oncology Advances|March 13, 2024
Preclinical evaluation of the third-generation, bi-steric mechanistic target of rapamycin complex 1-selective inhibitor RMC-6272 in NF2-deficient modelsSrirupa Bhattacharyya, Janet L Oblinger, Roberta L Beauchamp, et al.
Pageof 135